Background Several wireless ECG devices are commercially available for possible screening, monitoring and diagnosis of rhythms. The field is rapidly expanding, and some devices have demonstrated acceptable qualities. The objective was to evaluate the accuracy, usability and diagnostic capabilities of smartphone ECG in both patients and healthy controls. Methods We used a commercially available smartphone ECG device, connected wirelessly to a tablet, to record a 30-s lead I ECG in 144 subjects—20 of whom repeated the test after vigorous exercise. The subjects included 94 patients under standard calculated 12-lead ECG surveillance; transcripts were obtained shortly after the smartphone ECG was acquired. Results No significant differences were found in the QRS, frequency and QT intervals between the two modalities. Smartphone ECG recordings separated pathologic rhythms (atrial fibrillation (AF)/flutter, atrioventricular block, regular supraventricular rhythm, and pacing) from sinus rhythms with a sensitivity of 0.75 and a specificity of 0.97. The specific diagnosis of AF appeared in 11 patients and was detected with a sensitivity of 1 and a specificity of 0.94. There was a marginal decrease in the interpretability of the smartphone ECG after exercise. Inter- and intraobserver variability was low. Conclusions Smartphone ECG accurately measures most baseline intervals and has acceptable sensitivity and specificity for pathological rhythms, especially for AF. Vigorous activity has a minor influence on the readability of the PR interval. Elderly patients may face challenges in recording a smartphone ECG correctly without assistance. According to our findings, the smartphone ECG would be applicable as a screening device for pathological rhythms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.